English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Objective: To present an economic analysis of the lawsuits filed against medium-sized municipality. Methods: A retrospective descriptive study based on documents analysis from lawsuits filed in 2010 against a municipality. Results: Most of legal actions were represented by private attorneys and contained prescriptions provided by private physicians. Advance relief was granted to 88.8% of these actions. The drug/patient cost through the courts was around 200 times higher than expenses with basic component drugs of pharmaceutical care. 50.0% of the total cost with drugs acquired through the courts were represented by antineoplastic agents and immunomodulators drugs, which were provided to only 8.0% of the litigant patients. Drugs present in the specialized pharmaceutical assistance component and innovative drugs represented, respectively, 36.8% and 16.0% of the total cost. Conclusions: Drugs requested by legal proceedings have an average cost per patient much higher if compared to the basic component of pharmaceutical care. Significant portion of this cost is related to the new drug application, as well as antineoplastic agents and immunomodulators drugs. Palavras-chave: assistência farmacêutica, acesso aos serviços de saúde, direito à saúde, uso de medicamentos, economia da saúde Recebido em: 03/11/2015. Aprovado para publicação em: 07/12/2015 1. Mestranda, Universidade do Sul de Santa Catarina, Centro de Ciências da Saúde, Tubarão, Santa Catarina, Brasil. 2. Mestranda, Universidade de Brasília, Programa de Pós-Graduação em Ciências e Tecnologias em Saúde, Brasília, DF, Brasil. 3. Professora, Universidade de Brasília, Distrito Federal, Brasil. 4. Professora, Universidade Federal de Saúde de Porto Alegre; Porto Alegre, Rio Grande do Sul, Brasil. 5. Professora, Universidade de Brasília, Programa de Pós-Graduação em Ciências e Tecnologias em Saúde, Brasília, DF, Brasil. Potenciais conflitos de interesse: Nada a declarar. Fontes de financiamento do estudo: Não houve. Originado do trabalho de dissertação de Alexandra Ferro de Melo, Universidade do Sul de Santa Catarina, 2013. Autor para Correspondência: Dayani Galato Programa de Pós-Graduação em Ciências e Tecnologias em Saúde, Universidade de Brasília Centro Metropolitano, conjunto A, lote 01, Prédio Unidade de Ensino e Docência (UED) Ceilândia Sul Brasília DF. CEP: 72220-900. E-mail: dayani.galato@gmail.com Telefone/FAX: (061)3107-8416. ARTIGO ORIGINAL ORIGINAL ARTICLE

Uma abordagem econômica de processos judiciais de medicamentos impetrados contra um município do sul do Brasil